140 related articles for article (PubMed ID: 38140129)
1. Fluorinated Cell-Penetrating Peptide for Co-Delivering siHIF-1α and Sorafenib to Enhance In Vitro Anti-Tumor Efficacy.
Wan Y; Yang Y; Lai Q; Wang W; Wu M; Feng S
Pharmaceutics; 2023 Dec; 15(12):. PubMed ID: 38140129
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth.
Liu XQ; Xiong MH; Shu XT; Tang RZ; Wang J
Mol Pharm; 2012 Oct; 9(10):2863-74. PubMed ID: 22924580
[TBL] [Abstract][Full Text] [Related]
3. Effect of siRNA targeting HIF-1alpha combined L-ascorbate on biological behavior of hypoxic MiaPaCa2 cells.
Chen C; Tang P; Yue J; Ren P; Liu X; Zhao X; Yu Z
Technol Cancer Res Treat; 2009 Jun; 8(3):235-40. PubMed ID: 19445542
[TBL] [Abstract][Full Text] [Related]
4. Effect of small interference RNA targeting HIF-1alpha mediated by rAAV combined L: -ascorbate on pancreatic tumors in athymic mice.
Chen C; Sun J; Liu G; Chen J
Pathol Oncol Res; 2009 Mar; 15(1):109-14. PubMed ID: 18509748
[TBL] [Abstract][Full Text] [Related]
5. Design and evaluation of a stearylated multicomponent peptide-siRNA nanocomplex for efficient cellular siRNA delivery.
Wan Y; Moyle PM; Gn PZ; Toth I
Nanomedicine (Lond); 2017 Feb; 12(4):281-293. PubMed ID: 28093948
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound-guided RNA interference targeting HIF-1 alpha improves the effects of transarterial chemoembolization in rat liver tumors.
Chen CS; Zhao Q; Qian S; Li HL; Guo CY; Zhang W; Yan ZP; Liu R; Wang JH
Onco Targets Ther; 2015; 8():3539-48. PubMed ID: 26664137
[TBL] [Abstract][Full Text] [Related]
7. Dynamic Contrast Enhanced MRI Assessing the Antiangiogenic Effect of Silencing HIF-1α with Targeted Multifunctional ECO/siRNA Nanoparticles.
Malamas AS; Jin E; Gujrati M; Lu ZR
Mol Pharm; 2016 Jul; 13(7):2497-506. PubMed ID: 27264671
[TBL] [Abstract][Full Text] [Related]
8. A codelivery system loaded with PDL1-siRNA and sorafenib enhances the therapeutic effect of sorafenib on hepatocellular carcinoma via TAT-poly-SS-lysine modified chitosan.
Chen Y; Jiang Z; Yan Z; Liu J; Lai Y; Li L; Lin X; Lin J
Int J Biol Macromol; 2024 Apr; 263(Pt 1):130162. PubMed ID: 38365149
[TBL] [Abstract][Full Text] [Related]
9. Suppression of retinal neovascularization by shRNA targeting HIF-1alpha.
Xia XB; Xiong SQ; Xu HZ; Jiang J; Li Y
Curr Eye Res; 2008 Oct; 33(10):892-902. PubMed ID: 18853324
[TBL] [Abstract][Full Text] [Related]
10. [Study on suppression of hypoxia inducible factor-1 alpha and vascular endothelial growth factor expression by siRNA targeting hypoxia inducible factor-1 alpha].
Xiong SQ; Xia XB; Xu HZ; Li Y
Zhonghua Yan Ke Za Zhi; 2007 Nov; 43(11):1028-35. PubMed ID: 18307948
[TBL] [Abstract][Full Text] [Related]
11. Silencing of HIF-1α/CD73 axis by siRNA-loaded TAT-chitosan-spion nanoparticles robustly blocks cancer cell progression.
Hajizadeh F; Moghadaszadeh Ardebili S; Baghi Moornani M; Masjedi A; Atyabi F; Kiani M; Namdar A; Karpisheh V; Izadi S; Baradaran B; Azizi G; Ghalamfarsa G; Sabz G; Yousefi M; Jadidi-Niaragh F
Eur J Pharmacol; 2020 Sep; 882():173235. PubMed ID: 32574672
[TBL] [Abstract][Full Text] [Related]
12. Co-delivery of siRNA and hypericin into cancer cells by hyaluronic acid modified PLGA-PEI nanoparticles.
Li Y; Zhang J; Wang B; Shen Y; Ouahab A
Drug Dev Ind Pharm; 2016; 42(5):737-46. PubMed ID: 26472259
[TBL] [Abstract][Full Text] [Related]
13. Delivery of siHIF-1α to Reconstruct Tumor Normoxic Microenvironment for Effective Chemotherapeutic and Photodynamic Anticancer Treatments.
Chen X; Jin R; Jiang Q; Bi Q; He T; Song X; Barz M; Ai H; Shuai X; Nie Y
Small; 2021 Jun; 17(25):e2100609. PubMed ID: 34032365
[TBL] [Abstract][Full Text] [Related]
14. [Stem cell factor enhances invasive ability of BxPC-3 cells via hypoxia-inducible factor 1α (HIF-1α)].
Zhang M; Guo K; Li Q; Wang Y; Zhang L; He T; Wan B; Wang X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Jul; 33(7):903-908. PubMed ID: 28712397
[TBL] [Abstract][Full Text] [Related]
15. A cathepsin B/GSH dual-responsive fluorinated peptide for effective siRNA delivery to cancer cells.
Shi Z; Yang Y; Guo Z; Feng S; Wan Y
Bioorg Chem; 2023 Jun; 135():106485. PubMed ID: 36963370
[TBL] [Abstract][Full Text] [Related]
16. siRNA targeting HIF-1alpha induces apoptosis of pancreatic cancer cells through NF-kappaB-independent and -dependent pathways under hypoxic conditions.
Chen C; Yu Z
Anticancer Res; 2009 Apr; 29(4):1367-72. PubMed ID: 19414389
[TBL] [Abstract][Full Text] [Related]
17. The transcriptional activator hypoxia inducible factor 2 (HIF-2/EPAS-1) regulates the oxygen-dependent expression of erythropoietin in cortical astrocytes.
Chavez JC; Baranova O; Lin J; Pichiule P
J Neurosci; 2006 Sep; 26(37):9471-81. PubMed ID: 16971531
[TBL] [Abstract][Full Text] [Related]
18. Cell penetrating peptide functionalized perfluorocarbon nanoemulsions for targeted cell labeling and enhanced fluorine-19 MRI detection.
Hingorani DV; Chapelin F; Stares E; Adams SR; Okada H; Ahrens ET
Magn Reson Med; 2020 Mar; 83(3):974-987. PubMed ID: 31631402
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of hif-1α mediated hypoxia-induced permeability changes in bladder endothelial cells.
Liu C; Shui CL; Wang Q; Luo H; Gu CG
Braz J Med Biol Res; 2017 Dec; 51(2):e6768. PubMed ID: 29267502
[TBL] [Abstract][Full Text] [Related]
20. RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model.
Gillespie DL; Aguirre MT; Ravichandran S; Leishman LL; Berrondo C; Gamboa JT; Wang L; King R; Wang X; Tan M; Malamas A; Lu ZR; Jensen RL
J Neurosurg; 2015 Feb; 122(2):331-41. PubMed ID: 25423275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
